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Abstract
Regular physical activity reduces the risk of several site-specific cancers in humans and suppresses tumour growth in animal 
models. The mechanisms through which exercise reduces tumour growth remain incompletely understood, but an intriguing 
and accumulating body of evidence suggests that the incubation of cancer cells with post-exercise serum can have powerful 
effects on key hallmarks of cancer cell behaviour in vitro. This suggests that exercise can impact tumour biology through 
direct changes in circulating proteins, RNA molecules and metabolites. Here, we provide a comprehensive narrative overview 
of what is known about the effects of exercise-conditioned sera on in vitro cancer cell behaviour. In doing so, we consider the 
key limitations of the current body of literature, both from the perspective of exercise physiology and cancer biology, and we 
discuss the potential in vivo physiological relevance of these findings. We propose key opportunities for future research in 
an area that has the potential to identify key anti-oncogenic protein targets and optimise physical activity recommendations 
for cancer prevention, treatment and survivorship.
Keywords Exercise · Physical activity · Cancer prevention · Cancer therapy · Cancer cell growth · Cancer cell 
proliferation · Cancer cell apoptosis · Exercise-conditioned serum
Introduction and overview
Cancer incidence is high worldwide, with an estimated 
19.3 million new cancer cases and almost 10 million can-
cer deaths in 2020 (Sung et al. 2021). It is estimated that 
the global cancer burden will increase to 28.4 million cases 
in 2040 (Sung et al. 2021). Female breast cancer is now 
the most commonly diagnosed cancer globally, account-
ing for 11.7% of all new cases, followed by lung (11.4%), 
colorectal (10.0%), and prostate (7.3%) cancers (Sung et al. 
2021). Cancer incidence rates rise uniformly with increas-
ing Human Development Index (a quantitative indicator 
of a countries development status); the incident rate for 
all cancers is around 2.5 times higher in the most devel-
oped versus the least developed countries (Bray et al. 2018; 
Sung et al. 2021). The increase in morbidity and prema-
ture death related to cancer incidence exerts a substantial 
human cost and places considerable pressure on healthcare 
systems (Torre et al. 2016). Whilst the aetiology of can-
cer is complex, there is a modifiable component to cancer 
risk and outcome, with estimates that as many as 40% of all 
cancers could be prevented through alteration of lifestyle 
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risk factors at the population level, including an increase in 
physical activity (Wilson et al. 2018). Indeed, regular physi-
cal activity is a central tenet of international cancer preven-
tion recommendations (Rock et al. 2020). Moreover, regular 
physical activity after cancer diagnosis is associated with a 
reduced risk of tumour recurrence and mortality in patients 
with colon, breast or prostate cancer, supporting a role for 
physical activity as an adjunct cancer therapy (Ballard-Bar-
bash et al. 2012).
At present, the physiological and molecular mechanisms 
underlying the beneficial impact of physical activity on can-
cer risk and outcome are largely unclear. Part of the effect 
may be driven indirectly through the positive impact of phys-
ical activity on body mass and composition; indeed, many 
endogenous cancer risk factors are strongly associated with 
adiposity, including insulin resistance and circulating con-
centrations of sex hormones, insulin-like growth factors and 
inflammatory cytokines (McTiernan 2008). However, there 
is also accumulating evidence that exercise and physical 
activity can promote physiological changes that directly alter 
tumour growth and behaviour (Christensen et al. 2018). This 
includes improvements in immune function and immune sur-
veillance (Idorn and Hojman, 2016), but emerging evidence 
also suggests that other serological changes elicited by exer-
cise can also be anti-carcinogenic, as evidenced by altera-
tions in in vitro cancer cell growth and behaviour following 
incubation with post-exercise serum (Hojman et al. 2011; 
Orange et al. 2020). These findings suggest that physical 
activity/exercise can promote the release of metabolites, pro-
teins or RNA species with anti-tumorigenic properties. Fur-
thering our understanding of these effects has the potential 
to isolate novel therapeutic targets and to enhance our ability 
to develop specific physical activity recommendations for 
cancer prevention, treatment and survivorship.
The purpose of this narrative review is to summarise the 
current state of evidence for the effects of exercise-condi-
tioned serum on cancer cell behaviour in vitro. In doing so, 
we consider the key limitations of the current body of lit-
erature, both from the perspectives of exercise physiology 
and in vitro cancer biology, and we also discuss the potential 
in vivo physiological relevance of these findings. In addi-
tion, throughout the review, we highlight key opportunities 
and provide a comprehensive roadmap for future research 
to improve our understanding of the beneficial effects of 
exercise on the prevention and treatment of cancer.
Physical activity, exercise and cancer: 
epidemiological evidence
Strong epidemiological evidence suggests that people who 
are regularly physically active have a lower risk of devel-
oping common cancer types. The 2018 Physical Activity 
Guidelines Advisory Committee (PAGAC) Scientific 
Report concluded that achieving the highest versus low-
est level of physical activity reduces the risk of develop-
ing seven different cancers; namely colon, breast, kidney, 
endometrium, bladder, and stomach cancer, and oesopha-
geal adenocarcinoma (Physical Activity Guidelines Advi-
sory Committee 2018). Relative risk reductions ranged 
from approximately 10% to 20% in magnitude (McTier-
nan et al. 2019). These conclusions were supported by a 
2018 review by the American College of Sports Medicine 
(ACSM) Roundtable, which further determined that physi-
cal activity also protects against liver cancer (Patel et al. 
2019). Moreover, the ACSM Roundtable found moderate 
associations between greater amounts of post-diagnosis 
physical activity and decreased cancer-specific mortal-
ity in colon, breast, and prostate cancers, with a relative 
risk reduction of approximately 30% (Patel et al. 2019). 
The World Cancer Research Fund/American Institute for 
Cancer Research (WCRF/AICR) 2018 Continuous Update 
Project concluded that the evidence for a protective effect 
of physical activity was strong for colon, postmenopau-
sal breast, and endometrial cancers, and was limited but 
suggestive for premenopausal breast, oesophageal, lung, 
and liver cancers (World Cancer Research Fund/Ameri-
can Institute for Cancer Research 2018). Therefore, whilst 
there are some discrepancies between reports regarding the 
strength of evidence for specific cancer sites, the epide-
miological data are clearly supportive for physical activity 
as a strategy to reduce incident cancer, particularly for 
colon, breast and endometrial cancers.
It is noteworthy that almost all of the epidemiological 
evidence relates to leisure-time (i.e. active recreation, struc-
tured exercise and sports) and occupational aerobic physical 
activity (Physical Activity Guidelines Advisory Commit-
tee 2018; World Cancer Research Fund/American Institute 
for Cancer Research 2018). There is much less data on the 
association between cancer risk and physical activity in the 
household and transport domains. Similarly, despite accu-
mulating evidence supporting a role for resistance exercise 
in cancer survivorship (Schmitz et al. 2019), and the fact 
that resistance exercise is recommended for overall health 
(Physical Activity Guidelines Advisory Committee Sci-
entific Report 2018; Garber et al. 2011), there is a lack of 
epidemiological data for this type of activity in relation to 
cancer incidence. This paucity of evidence is highlighted in 
physical activity guidelines for cancer prevention, with the 
American Cancer Society (ACS) recommending that adults 
should engage in 150–300 min/week of moderate-intensity 
or 75–150 min/week of vigorous-intensity aerobic physical 
activity (or an equivalent combination of both), with less 
specific instructions for resistance-type exercise (‘some mus-
cle‐strengthening activity at least 2 days each week’) (Rock 
et al. 2020).
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The best available evidence suggests that there is a 
dose–response relationship between the amount of physi-
cal activity and the risk of several cancer types. A recent 
pooled analysis of data from over 750,000 adults followed 
for 10 years showed linear dose–response associations 
between physical activity and incidence of breast, colon, 
and endometrial cancer, oesophageal adenocarcinoma, 
and head and neck cancer (Matthews et al. 2019). For 
these cancer types, engaging in physical activity above 
the recommended amount (i.e. > 300 min·wk−1 of moder-
ate-intensity physical activity) was associated with addi-
tional risk reduction (Matthews et al. 2019). Importantly, 
there does not appear to be a threshold of physical activity 
below which there is no cancer-preventive benefit, suggest-
ing that any level of physical activity is better than none 
(Mctiernan et al. 2019); however, the magnitude of the 
reduction in cancer risk for the same ‘dose’ of physical 
activity does appear to be less pronounced compared with 
cardiovascular and metabolic disease (Rock et al. 2020).
Despite increasing efforts to shape the dose–response 
curve between physical activity dose and cancer inci-
dence (Physical Activity Guidelines Advisory Committee 
2018; World Cancer Research Fund/American Institute for 
Cancer Research, 2018; Matthews et al. 2019), the influ-
ence of exercise intensity remains unclear. The totality 
of epidemiological evidence suggests that moderate-to-
vigorous-intensity physical activity is inversely associated 
with several cancer types (Patel et al. 2019; Rock et al. 
2020); however, the evidence relating to the independent 
effects of light- moderate-, and vigorous-intensity physi-
cal activity is limited, which is, at least, partly due to the 
wide range of methods used to classify intensity of physi-
cal activity, and the challenges in accurately demarcating 
intensity domains on a large scale. In a subset analysis of 
309,881 adults, Matthews et al. (2019) reported overall 
negative associations with risk of breast and kidney cancer 
for moderate-intensity activity, while vigorous-intensity 
activity was associated with reduced risk of endometrial 
cancer. However, there was large uncertainty around the 
estimates, highlighting that more evidence is needed to 
better understand the optimal intensity of physical activity 
for cancer risk reduction.
In summary, there is strong epidemiological evidence 
that regular aerobic physical activity in the leisure-time or 
occupational domain protects against several cancer types, 
mostly in a dose–response manner. Aside from the impor-
tance of these observations from the perspective of exer-
cise prescription and promotion, and public health, they 
have also stimulated substantial research interest towards 
exploring the physiologically relevant effects of exercise 
that impact upon tumour genesis, proliferation and metas-
tasis (Ashcraft et al. 2016; Eschke et al. 2019).
Putative biological mechanisms
The prevailing hypothesis with regard to the mechanisms 
underlying the anti-oncogenic effects of physical activ-
ity focuses on its interactions with energy balance and 
adiposity. Excess body fatness resulting from a positive 
energy balance increases insulin resistance and chronic 
low-grade inflammation, which are known to be important 
risk factors for cancer (McTiernan 2008). Raised fasting 
and postprandial circulating insulin increases the bioavail-
ability of insulin-like growth factor 1 (IGF-1) through the 
inhibition of hepatic IGF binding protein 1 (IGFBP-1) and 
IGFBP-2 secretion (Brismar et al. 1994), and increases 
hepatic synthesis of IGF-1 through the upregulation of 
growth hormone receptors (Leung et al. 2000). Circulating 
IGF-1 is positively related to several cancer types (Knup-
pel et al. 2020), and is known to stimulate healthy and 
malignant cell proliferation through ligand binding to the 
IGF-1 receptor and activation of downstream intracellular 
pathways, including the PI3K-Akt-mTOR and mitogen-
activated protein kinase (MAPK) pathways (Iams and 
Lovly 2015). Chronic low-grade inflammation induced by 
excess adiposity, characterised by macrophage infiltration 
and secretion of pro-inflammatory cytokines, can promote 
DNA damage and genomic instability through the induc-
tion of reactive oxygen and nitrogen species (Coussens 
and Werb 2002). Pro-inflammatory cytokines, such as 
tumour necrosis factor alpha (TNF- α) and interleukin-1 
beta (IL-1β), also stimulate cell proliferation and invasive 
capacity of pre-malignant cells, causing a shift to a neo-
plastic phenotype (Baird et al. 2016; Esquivel-Velázquez 
et al. 2015). Other putative biological mechanisms related 
to excess body fat include enhanced circulating leptin, 
which is a growth factor in normal and malignant cells, 
mainly through JAK/STAT signalling (Hu et al. 2002), 
and increased sex steroid hormones. Excess body fat pro-
motes the conversion of androgen precursors to oestrogen 
through enhanced aromatase activity in the adipose tissue, 
which may increase the risk of postmenopausal, oestrogen-
receptor-positive breast cancer (Gérard and Brown 2018). 
Similarly, obesity is linked to lower levels of serum sex 
hormone-binding globulin (Cooper et al. 2015), which 
may increase the risk of hormone-sensitive cancers, such 
as prostate and postmenopausal breast cancer, by increas-
ing exposure to bioavailable testosterone and oestrogen, 
respectively.
Physical activity energy expenditure largely explains 
variations in total daily energy expenditure (Thompson 
et al. 2009, 2015) and, for this reason, is known to be 
important for long-term weight maintenance, as well as 
the avoidance of weight regain after weight loss (Don-
nelly et al. 2009). Thus, much of the protective effect of 
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physical activity on cancer risk has been ascribed to indi-
rect, adiposity-dependent mechanisms (described above) 
(McTiernan 2008). However, recent epidemiological evi-
dence shows that physical activity is associated with a 
reduced risk of common cancers independently of body 
mass index, with the exception of endometrial cancer 
(Matthews et al. 2019; Moore et al. 2016). A recent Men-
delian randomisation study using UK Biobank data also 
showed that physical activity was inversely associated 
with colorectal and breast cancers independent of adi-
posity (Papadimitriou et al. 2020). Furthermore, a meta-
analysis of randomised pre-clinical studies showed that 
exercise training alone (i.e. without dietary modification) 
suppresses tumour growth in rodents (Eschke et al. 2019). 
As such, there is a growing appreciation that the plethora 
of physiological responses to both acute and chronic physi-
cal activity and exercise may exert direct anti-tumorigenic 
effects (Christensen et al. 2018). This includes the mobili-
sation and redistribution of key immune-cell populations 
(e.g., natural killer T-cells) (Idorn and Hojman 2016). 
However, an intriguing and accumulating body of evidence 
also suggests that incubation of cancer cells with exercise-
conditioned serum (i.e. no immune cells) can also have 
powerful effects on key hallmarks of cancer cell behaviour 
(Orange et al. 2020). This suggests that exercise can have 
an impact on tumour biology through direct changes in 
the circulating transcriptome/metabolome/proteome and 
opens up a new and exciting area of research, with the 
potential to isolate key anti-oncogenic serological targets 
and to enhance our ability to develop optimal physical 





Exercise is a subcomponent of physical activity encompass-
ing planned, structured activities purposefully carried out to 
sustain or improve physical fitness (Caspersen et al. 1985; 
Dasso 2019). The onset of exercise results in a myriad of 
transient changes in serum that are dependent on relative 
exercise intensity, exercise duration and exercise mode 
(Contrepois et al. 2020; Guseh et al. 2020). One of the key 
hallmarks of cancerous cells is increased cell survival or 
viability (Ruiz-Casado et al. 2017); over the last decade, 
evidence has accumulated to suggest that the systemic 
alterations induced by exercise can have direct effects on 
cancer cell viability in vitro. This was first demonstrated 
by Rundqvist et al. (2013) who incubated the human pros-
tate cancer cell line, LNCaP, with serum collected from 
young healthy males before and 2 h after a 65 min bout 
of moderate-intensity aerobic exercise (50–65% V ̇O2max). 
The number of viable prostate cancer cells following a 96 h 
incubation with post-exercise serum in vitro was reduced 
by ~ 30% when compared with serum collected pre-exercise 
(Rundqvist et al. 2013). This finding has since been repli-
cated using LNCaP cells and sera derived from a comparable 
population (young healthy men) (Baldelli et al. 2020), and 
it has also demonstrated in human breast cancer cell lines 
using sera derived from young healthy women and women 
with breast cancer (Baldelli et al. 2020; Dethlefsen et al. 
2016, 2017a), human colon cancer cell lines using sera 
derived from colon cancer survivors (Devin et al. 2019), 
and human lung cancer cells using sera derived from healthy 
men (Kurgan et al. 2017). Indeed, Orange et al. (2020) 
recently summarised studies that had examined the effect of 
serum collected immediately post-exercise on in vitro can-
cer cell viability and, in a meta-analysis, reported an 8.6% 
decrease in cell viability compared with serum collected 
pre-exercise (Fig. 1). Importantly, there is no evidence that 
exercise-conditioned serum has an effect on growth in non-
malignant ‘control’ cell lines, suggesting that the serologi-
cal effects of exercise are suppressive specifically in cancer 
cells that harbour aberrant activation of signalling pathways 
(Kurgan et al. 2017; Rundqvist et al. 2013). In addition, the 
short-term effects on cancer cell viability have been shown 
to translate into a strong reduction (30–80%) in longer term 
‘clonogenic potential’, that is the ability of the cancer cells to 
grow and form new colonies, which is considered the most 
robust in vitro measure of cell growth (Baldelli et al. 2020; 
Kurgan et al. 2017). Moreover, mice inoculated with cancer 
cells conditioned in (human) post-exercise sera subsequently 
developed less tumours compared with mice injected with 
cells conditioned in pre-exercise serum (Dethlefsen et al. 
2017a).
The anti-proliferative effect of post-exercise serum on 
cancer cells could result from a reduction in the rate of cell 
proliferation, the induction of cell death (e.g., apoptosis), or 
a combination of the two. Further, the relative contribution 
or importance of each of these mechanisms could change 
depending on the time point post-exercise, the cancer cell 
type, the serum donor population, and the characteristics 
of the exercise bout. A very limited number of studies have 
examined this using appropriate methods in humans; how-
ever, it has tentatively been suggested that acute-exercise-
conditioned serum does not affect cancer cell apoptosis, sug-
gesting that the growth-inhibitory effect is (largely) mediated 
through a suppression of proliferative signalling pathways 
(Devin et al. 2019; Rundqvist et al. 2013). This is somewhat 
surprising since post-exercise increases in serum concen-
trations of myokines (skeletal muscle-derived cytokines/
peptides), such as interleukin (IL)-6, have previously been 
associated with cancer cell apoptosis in vitro (Bharti et al. 
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2016; Liu et al. 2010). Yet, consideration should be given 
to the timing of post-exercise sample collection, as demon-
strated by a study showing that exercise-conditioned sera 
from a mouse model induces cancer cell apoptosis through 
an increase in caspase activity immediately, but not 2 h, 
post-exercise (Hojman et al. 2011). Only one of the afore-
mentioned human studies measured apoptosis after applying 
human serum collected immediately post-exercise (Devin 
et al. 2019), whilst both studies examined serum collected 
2 h post-exercise (Devin et al. 2019; Rundqvist et al. 2013).
It is also currently unclear how long the suppressive 
effect on cancer cell growth persists after exercise because 
studies have either only collected samples at one time point 
post exercise (Hwang et al. 2020; Rundqvist et al. 2013) 
or, where multiple samples have been collected, they have 
not been collected at consistent time points across studies 
(Baldelli et al. 2020; Dethlefsen et al. 2016, 2017a; Devin 
et al. 2019; Kurgan et al. 2017). In some cases, the effect has 
been short-lived and lost in serum collected 2 h post exercise 
(Devin et al. 2019), whilst others have been able to detect an 
effect of serum for up to 24 h post exercise (Baldelli et al. 
2020; Kurgan et al. 2017) (Table 1). Future research in this 
area should carefully map the time course of the effects of 
exercise-conditioned sera on cell proliferation and cell death 
in a range of cancer cell types with different genetic profiles, 
following a range of exercise bouts, using serum from vari-
ous populations with detailed health status.
Although these studies provide preliminary evidence 
that acute exercise-conditioned serum suppresses cancer 
cell growth, they should be interpreted with some caution 
as there are also important methodological limitations. 
First, they almost exclusively make inferences based on 
a comparison of pre- (i.e. inactive) compared to post-
exercise serum and do not include a time-matched rest-
ing control condition (Baldelli et al. 2020; Devin et al. 
2019; Hwang et al. 2020; Kurgan et al. 2017; Rundqvist 
et al. 2013). On the face of it, a comparison of pre- and 
post-exercise serum may seem like a reasonable study 
design, but it means that the anti-oncogenic effects can-
not be specifically attributed to exercise alone. Indeed, the 
serum profile may be subject to circadian fluctuation over 
time (Carroll et al. 2019), and repeated venous blood sam-
pling (used in some studies) may result in physiological 
changes that could also have anti-tumorigenic effects, for 
example an increase in circulating adrenaline (Carruthers 
et al. 1970). Indeed, plasma cytokines have been shown 
to increase from pre- to post-acute aerobic exercise, but 
this increase was similar in magnitude and not statistically 
different from a time-matched control condition (Windsor 
et al. 2018). Only Dethlefsen et al. (2017a) included a sep-
arate resting control condition within their study design; 
however, they did not collect a ‘pre’ sample in either the 
resting or the exercise conditions, meaning that day-to-day 
variation in the serological profile could confound their 
analysis. Taken together, there is a clear need for further 
studies that include a time-matched inactive control condi-
tion, in a randomised, crossover design, so that the effects 
of acute exercise can be isolated. It is also worth high-
lighting that some studies have made inferences based on 
comparisons of sera pooled from all individuals pre- and 
Fig. 1  Forest plot showing the pooled effect of serum collected immediately post exercise on cancer cell proliferation. Figure  reproduced from 
Orange et al. (2021), distributed under an open access Creative Common CC BY license
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post-exercise and this approach may mask important inter-
individual differences in response (Rundqvist et al. 2013).
It should also be noted that there is a high level of vari-
ability in the reported effects of acute-exercise-conditioned 
serum on in vitro cancer cell viability in studies conducted to 
date (Orange et al. 2020). This is perhaps unsurprising given 
the diverse range of populations, cancer cell lines, and exer-
cise characteristics that have been included across different 
independent studies, all of which could be hypothesised to 
alter the presence and/or magnitude of the effect of exercise-
conditioned serum on growth/viability. Interestingly, in the 
meta-analysis by Orange et al. (2020), covarying for differ-
ent cancer types (breast vs other), disease status (healthy vs 
cancer survivor), or exercise mode (continuous vs interval 
training) did not alter the effect magnitude or heterogene-
ity. However, these findings should be treated with some 
caution given the small number of studies included and the 
fact that this analysis was largely based on comparisons of 
effect sizes between independent studies (i.e. with different 
methodologies) rather than those reported within the same 
studies (i.e. where methodologies are standardised). As an 
example of the potential for factors, such as participant char-
acteristics, to have an impact on the effect of exercise-condi-
tioned serum on cancer cell behaviour, one study reported an 
anti-growth effect of post-exercise serum from older (mean 
age 63 years) but not younger (mean age 28 years) men in 
prostate cancer cells following 60 min of moderate-intensity 
cycling (Hwang et al. 2020).
The mode, intensity and duration of exercise is known to 
have a key impact on the serological response during exer-
cise and in the post-exercise recovery period (Metcalfe et al. 
2015; Stokes et al. 2013; Williams et al. 2013). For this 
Table 1  Map of post-exercise effects on cancer cell viability / growth
Wmax maximal power output achieved during an incremental exercise test to volitional exhaustion, HIIE High-intensity interval exercise, HRmax 
maximal heart rate
↓Decreased cancer cell viability/growth; ↔ , no change in cancer cell viability /growth
Study Participants Cancer cell line Exercise bout Post-exercise time point
0 1-h 2-h 4-h 24-h
Baldelli et al. (2020) Young and healthy males 
and females (n = 30)
LNCaP (prostate) and 
MDA-MB-231 (breast)
Cycling. Progressive 
aerobic (4 × 5-min at 50%, 
55%, 60%, 70% Wmax) 
and HIIE (10 × 90-s at 
90% Wmax interspersed 
with 180-s at 55% Wmax) 
followed by exercise to 
exhaustion at 90% Wmax
↓ ↓ ↓
Dethlefsen et al. (2016) Middle-aged women  
with breast cancer  
(n = 20)
MCF-7 and MDA-MB-231 
(breast)
30 min warm up followed 
by 60 min of whole-body 
resistance exercise and 
30 min of HIIE cycling 
(80–85% HRmax). No 
other details provided
↓
Dethlefsen et al. (2017a ) Young healthy females 
(n = 7)
MCF-7 and MDA-MB-231 
(breast)
Moderate intensity continu-
ous cycling (2-h at 55% 
 VO2max)
↓
Devin et al. (2019) Male colon cancer survivors 
(n = 10)
CaCO-2 and LoVo (colon) HIIE cycling (4 × 4 min at 
85–95% HRmax)
↓  ↔ 
Hwang et al. (2020) Healthy young males 
(n = 12)
PC3 and LNCaP (prostate) Moderate intensity continu-
ous cycling (20-min at 
50%  VO2max followed by 
45-min at 65%  VO2max)
↓
Healthy older males  
(n = 12)
PC3 and LNCaP (prostate) Moderate intensity continu-
ous cycling (20-min at 
50%  VO2max followed by 
45-min at 65%  VO2max)
 ↔ 
Kurgan et al. (2017) Healthy young males  
(n = 6)
A549 (lung) HIIE cycling (6 × 1-min at 
90% Wmax)
↓ ↓ ↓
Rundqvist et al. (2013) Young healthy males 
(n = 10)
LNCaP (colon) Moderate intensity continu-
ous cycling (20-min at 
50%  VO2max followed by 
40-min at 65%  VO2max)
↓
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reason, it can be speculated that different modes, durations 
and intensities of exercise will also differentially affect the 
anti-oncogenic effects of acute-exercise-conditioned serum. 
A significant serum-stimulated reduction in human cancer 
cell viability / growth has been demonstrated using sev-
eral different acute exercise protocols (Table 1), including 
moderate-intensity steady-state aerobic exercise (Dethlefsen 
et al. 2017a; Hwang et al. 2020; Rundqvist et al. 2013), high-
intensity aerobic interval exercise (HIIE) (Devin et al. 2019; 
Kurgan et al. 2017), a combined session of HIIE and whole-
body resistance exercise (Dethlefsen et al. 2016), and a com-
bined incremental aerobic and HIIE session (Baldelli et al. 
2020). Yet, with the exception of Dethlefsen et al. (2017a) 
who showed a similar reduction in breast cancer cell growth 
after both 1- and 2-h of moderate-intensity cycling, no single 
study has made a direct comparison of the effects of differ-
ent modes, intensities, or durations of acute exercise within 
the same participants, which makes inferences on the effect 
of characteristics challenging. There is a clear need for this 
knowledge gap to be addressed by future research studies 
in this area. It is also interesting to note that the majority of 
the exercise bouts have involved prolonged exercise dura-
tions (1–2 h) (Dethlefsen et al. 2016, 2017a; Hwang et al. 
2020; Rundqvist et al. 2013) or, in some cases, exercise to 
the point of volitional exhaustion (Baldelli et al. 2020). It 
is currently unknown whether moderate-intensity aerobic 
exercise of a shorter duration (e.g. bouts of 10–30 min), or 
acute resistance exercise alone, also have a growth-inhibi-
tory effect on cancer cells. These are important questions 
because prolonged moderate-intensity aerobic exercise last-
ing > 60 min or exercise of a vigorous intensity may not be 
feasible for some cancer survivors or those with the highest 
risk of developing common cancers, such as older, over-
weight adults with multimorbidity. Establishing the impact 
of different modes, durations and intensities of exercise on 
the anti-carcinogenic effects of exercise-conditioned serum 
will be of key importance to the optimisation of exercise 
recommendations for cancer prevention and treatment.
Effects of exercise training
Another important aspect to consider is the effect of sera 
conditioned by regular exercise training (chronic exercise) 
on cancer cell behaviour, once the effects of the last bout 
of exercise (i.e. acute exercise) have subsided. A series of 
early cross sectional studies demonstrated lower LNCaP 
prostate cancer cell growth and higher apoptosis when 
incubated with sera from regular exercisers as compared 
with inactive controls (Barnard et al. 2003, 2007; Tymchuk 
et al. 2002). However, there was a large difference in body 
mass index between the exercise and control groups (26 vs 
38 kg/m2), which may explain much of the difference in 
serum-stimulated cancer cell behaviour (Barnard et al. 2007, 
2003; Tymchuk et al. 2002). The same research group also 
identified that serum collected following a 2-week interven-
tion combining regular aerobic exercise and a low-fat diet 
reduced cancer cell growth and increased apoptosis in vitro; 
however, the effects of exercise cannot be isolated from the 
effects of diet in these studies (Barnard et al. 2006; Ngo 
et al. 2003; Tymchuk et al. 2001). In addition, the post-inter-
vention blood samples were drawn within a 24-h window 
following an acute bout of exercise (i.e. the final training ses-
sion) and, therefore, the findings are likely to reflect transient 
acute effects rather than a training effect per se (Barnard 
et al. 2006; Ngo et al. 2003; Tymchuk et al. 2001). Simi-
larly, a recent study by Schwappacher et al. (2020) reported 
reduced cell proliferation and increased apoptosis in human 
prostate and colon cancer cell lines that were incubated with 
post-training serum from patients with advanced stage can-
cer following 12 weeks of whole-body electromyostimula-
tion to mimic resistance training. However, the authors also 
collected the post-training blood samples 1 h following the 
last training session, and so the effect of training cannot be 
isolated from the effects of the last bout of exercise. This 
is also the case for a recent pre-clinical study in a rodent 
model, which showed reduced prostate cancer AT-1 cell 
growth following incubation with serum collected 24-h 
after the final session of an 11-week training programme 
(Opoku-Acheampong et al. 2019), a time point where the 
acute effects of exercise may still be present (Baldelli et al. 
2020; Kurgan et al. 2017).
Interestingly, a number of other recent publications pre-
sented no evidence of an effect of exercise training on can-
cer cell growth when post-training samples were collected 
greater than 1 day and no more than 7 days following the last 
exercise bout (Baldelli et al. 2020; Dethlefsen et al. 2016; 
Devin et al. 2019). This has been demonstrated using sera 
drawn from young healthy men on a prostate cancer cell line 
(Baldelli et al. 2020), serum drawn from men with colon 
cancer on colon cancer cell lines (Devin et al. 2019), and 
serum drawn from young healthy women (Baldelli et al. 
2020) and women with breast cancer (Dethlefsen et al. 2016) 
on breast cancer cell lines. These studies have involved short 
(4 weeks) (Devin et al. 2019), short-to-medium (9 weeks) 
(Baldelli et al. 2020), and longer term (6-month) (Dethlef-
sen et al. 2016) exercise training interventions, and all of 
them have demonstrated physiological adaptations following 
training, including an increase in V ̇O2peak/V ̇O2max (Baldelli 
et al. 2020; Dethlefsen et al. 2016; Devin et al. 2019). There-
fore, the lack of effect on cancer cell behaviour does not 
appear to be explained by an insufficient training stimulus 
per se. On the other hand, it is worth noting that these stud-
ies have either been conducted in healthy lean populations 
(Baldelli et al. 2020) or have shown only small (Devin et al. 
2019) or no (Dethlefsen et al. 2016) changes in body mass or 
body composition in overweight cancer patient populations 
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following training. Longer term exercise interventions, 
particularly involving a large volume of aerobic exercise, 
are likely to have positive impacts on body mass and body 
composition in overweight or obese individuals (Ohkawara 
et al. 2007; Slentz et al. 2004). From this perspective, it is 
worth highlighting that the study that applied a 6-month 
exercise intervention only required a single supervised exer-
cise session per week and reported low levels of adherence 
(mean attendance 66%) (Dethlefsen et al. 2016). Reductions 
in body fatness are known to drive changes in the circu-
lating plasma profile, including alterations in key proteins/
hormones/metabolites implicated in oncogenesis (McTier-
nan 2008). Thus, future studies should address the question 
of whether exercise training with and without weight loss 
results in different effects with regard to serum-stimulated 
cancer cell behaviour.
Another interesting question is whether the acute effects 
of exercise on cancer cell behaviour are still apparent after a 
period of regular exercise training. This is important because 
exercise training can diminish key skeletal-muscle signalling 
events (e.g. activation of 5′ AMP-activated protein kinase 
(AMPK)) (McConell et al. 2005, 2021) and alter skeletal 
muscle metabolism at the same (whole-body) relative exer-
cise intensity (e.g. %V ̇O2max), and this may have an impact 
on subsequent serological responses. To date, only the study 
by Baldelli et al. (2020) has considered this question using 
an appropriate design. They reported that the magnitude of 
the effect of acute exercise on prostate cancer cell growth 
may be attenuated by regular training, i.e. cell proliferation 
may be suppressed to a lesser extent following acute exercise 
after a period of training. The acute exercise bout used in 
this study involved a mixture of incremental aerobic exercise 
and HIIE, but was performed to exhaustion both pre- and 
post-training, so the attenuated effect on prostate cancer cell 
growth does not appear to be driven by changes in fitness 
and, hence, relative exercise intensity (Baldelli et al. 2020). 
Further studies evaluating whether the effect of acute exer-
cise on cancer cell growth is attenuated following training, 
and whether this correlates with alterations in the change in 
the serological profile during acute exercise, may provide 
key information to help untangle the molecular mechanisms 
underlying this phenomenon.
Acute exercise‑conditioned serum 
and cancer cell growth: signalling 
and molecular mechanisms
The increased rate of proliferation that is a hallmark of can-
cer cells is underpinned by multiple local genetic mutations 
in highly conserved signalling networks that, in healthy 
cells, regulate cell growth and division in response to 
both intracellular and extracellular stimuli (Fig. 2 (Shaw 
and Cantley 2006)). For example, in skeletal muscle cells, 
mTOR, and its upstream activators (e.g. PI3K, Akt, Ras) 
and downstream targets (e.g. p70s6k etc.), are responsive 
to both acute exercise (mechanical loading) and feeding 
(amino acids) and regulate protein synthesis and growth 
Fig. 2  Acute-exercise-conditioned serum inhibits signalling pathways 
involved in cell proliferation. Increased proliferation in cancer cells 
is underpinned by mutations in highly conserved signalling networks 
that are involved in cell growth and division. Exposure of cancer cells 
to acute-exercise-conditioned serum has been shown to alter phos-
phorylation of proteins in these signalling pathways in a way that 
reduces cell proliferation. For example, exercise-conditioned serum 
was shown to reduce phosphorylation of Akt, mTOR, p70s6k and Erk 
1/2 in human lung cancer cells (22). In addition, post-exercise serum 
has been suggested to support the Hippo tumour suppressor pathway 
(which involves activation of MST and LATS1/2) by inhibiting YAP/
TAZ in human breast cancer cells (18); although, further studies are 
required to determine this since similar results were not observed in 
other cancer cell types (e.g. colon cancer cells (18)). Figure  adapted 
from Kurgen et al. (2017) and reproduced under an open access Crea-
tive Common CC BY license
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(Hodson and Philp 2019). The proteins in this pathway are 
also commonly dysregulated, and hence hyperactive, in a 
large proportion of different cancer types (Shaw and Cantley 
2006). Kurgan et al. (2017) demonstrated that exposure to 
acute exercise-conditioned serum reduced phosphorylation 
of Akt, Erk 1/2, mTOR and p70S6K in human lung cancer 
cell lines, which was observed using serum obtained up to 
24 h post-exercise. This may, in part, explain the effects of 
acute exercise sera on lung cancer cell growth. Whether this 
pathway is also suppressed within other cancer cell types is 
plausible, but requires investigation.
Two studies have also investigated the effect of post-
exercise serum on the activation state of the Hippo tumour 
suppressor pathway (Fig. 2; Baldelli et al. 2020; Dethlefsen 
et al. 2017a), which is commonly inactivated in most can-
cers (Sebio and Lenz 2015; Serrano et al. 2013). This path-
way involves a kinase cascade from the tumour suppressors 
mammalian Mst1 and Mst2 to the oncoproteins YAP and 
TAZ, which are transcriptional coactivators of target genes 
involved in cell growth and survival (Fig. 2) (Pan 2010). 
Following the activation of the Hippo pathway, which can 
be achieved through ligand binding to G protein-coupled 
receptors (e.g., β-adrenergic receptors) (Yu et al. 2012), 
Mst1/2 is phosphorylated and activates LATS1/2, which in 
turn phosphorylates YAP/TAZ, resulting in the inhibition 
and degradation of YAP/TAZ in the cytosol (Han 2019). 
However, the data from these studies are far from conclu-
sive. Dethlefsen et al. (2017a) provided some evidence of 
increased phosphorylation, and thus inhibition, of the YAP 
protein, and reduced expression of its downstream target 
genes following incubation of breast cancer cells with post-
exercise serum. However, the increase in YAP phosphoryla-
tion was not statistically significant across all the time points 
assessed within the assay and was inconsistent across two 
different human breast cancer cell lines (MCF-7 and MDA-
MB-231 cells). Similarly, Baldelli et al. (2020) were unable 
to demonstrate a consistent suppression of Hippo-related 
signalling following incubation of cells with post-exercise 
serum, with increased YAP phosphorylation observed at one 
of six post-exercise time points in prostate cancer LNCaP 
cells, and no increase observed in triple-negative breast can-
cer MDA-MB-231 cells, despite consistent suppression of 
cell growth at all time points in both human cell lines. Taken 
together, it remains unclear whether activation of the Hippo 
pathway contributes to the anti-oncogenic effects of acute 
exercise (Orange et al. 2020).
The concentration of thousands of humoral factors are 
altered by acute exercise (Contrepois et al. 2020; Guseh et al. 
2020) and the exact factor(s) responsible for the suppres-
sion of growth signalling and the anti-oncogenic effects of 
acute-exercise-conditioned sera remains to be determined. 
To investigate the role that exercise-induced epinephrine 
and norepinephrine play in cancer cells, Dethlefsen et al. 
(2017a) supplemented post-exercise serum with an ß-adr-
energic signalling inhibitor (propranolol) prior to treatment 
of human breast cancer cells. They showed that this ablated 
the suppression of breast cancer cell growth in vitro, as well 
as tumour growth in mice following implantation with the 
treated cells. However, given that circulating epinephrine 
and norepinephrine concentrations return to basal levels 
within 3-h post moderate- and high-intensity exercise (Wil-
liams et al. 2013), this would not explain the suppression 
of cancer cell growth using serum obtained 24-h post exer-
cise that was observed in some studies (Baldelli et al. 2020; 
Kurgan et al. 2017), unless downstream priming effects are 
involved.
A number of others have hypothesised that cytokines and 
other peptides released from contracting skeletal muscle dur-
ing exercise (i.e. myokines) may play an important role in 
the effect of exercise sera on cancer cells (Hojman et al. 
2018). However, to date, few myokines have been systemati-
cally investigated in the context of acute-exercise-mediated 
suppression of cancer cell growth. Interleukin 6 (IL-6) is the 
most widely researched myokine, and studies have consist-
ently shown an exercise-induced increase in IL-6 mRNA 
within the contracting muscle, as well as increased levels of 
IL-6 in the circulation (Fischer 2006; Pedersen and Febbraio 
2008; Ruffino et al. 2016). Directly stimulating oestrogen-
receptor-positive breast cancer cells with IL-6 has been 
shown to reduce cell growth in vitro (Dethlefsen et al. 2013). 
In addition, IL-6 can elicit both pro-inflammatory and anti-
inflammatory processes, which likely depends on the cell 
source and whether IL-6 acts through classic or trans-signal-
ling (Rose-John 2012). IL-6 signalling is initiated by binding 
of IL-6 to the IL-6 receptor α (IL-6Rα) and subsequent bind-
ing to the ubiquitously expressed receptor subunit glyco-
protein 130 (gp130). IL-6Rα exists in a transmembrane and 
soluble form; binding of IL-6 to membrane bound IL-6Rα 
leads to anti-inflammatory classic signalling; whereas, bind-
ing of IL-6 to soluble IL-6Rα promotes pro-inflammatory 
trans-signalling (Reeh et al. 2019). A study using a mouse 
model with conditional expression of the IL6 gene showed 
that IL-6 derived from adipocytes increased macrophage 
infiltration of adipose tissue; whereas, IL-6 derived from 
myocytes and myeloid cells suppressed macrophage infil-
tration (Han et al. 2020). This opposing action of IL-6 was 
associated with a switch from trans-signalling to classic sig-
nalling (Han et al. 2020). Thus, as well as having a direct 
role in suppressing cancer growth, as evidenced by studies 
with oestrogen-receptor-positive breast cancer cells (Deth-
lefsen et al. 2013), IL-6 released from skeletal muscle during 
exercise may also play an indirect role through the induction 
of an anti-inflammatory environment. In further support of 
this notion, evidence exists demonstrating that IL-6 signal-
ling stimulates the release of anti-inflammatory cytokines 
IL-10 and IL-1ra from monocytes and macrophages, leading 
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to elevated levels of these cytokines in serum (Gleeson et al. 
2011; Steensberg et al. 2003).
Aoi et al. (2013) demonstrated that the secreted protein 
acidic-rich in cysteine (SPARC) is also released from skel-
etal muscle into the circulation following 30 min of aerobic 
exercise in both mice and humans. They showed that SPARC 
induces a reduction in growth in a human colon cancer cell 
line in vitro and that regular injection of a low dose of 
SPARC into mice (to mimic the rise during acute exercise) 
reduced formation of colon cancer lesions (Aoi et al. 2013). 
A similar reduction in the formation of colon cancer lesions 
was reported with regular exercise in wild-type but not in 
SPARC-null mice (Aoi et al. 2013). Hojman et al. (2011) 
conducted a systematic investigation of the effects of IL-10 
and IL-11, oncostatin M (OSM) and GDF5 on cancer cell 
behaviour using a mouse model. Of this panel of myokines, 
their data suggested that IL-10 and OSM are possible can-
didates mediating the effects of exercise on (breast) cancer 
cell proliferation. However, it should be noted that, since 
both of these studies are based on animal data, whether they 
are directly translatable to humans is unclear (Mak et al. 
2014). Indeed, both SPARC and OSM were also associated 
with increased apoptosis and caspase activity in these animal 
studies (Aoi et al. 2013; Hojman et al. 2011) and current 
human data suggests that apoptosis is not increased in can-
cer cells treated with exercise-condition serum (Devin et al. 
2019; Rundqvist et al. 2013). A range of other myokines 
are purported to have anti-carcinogenic effects, including 
irisin (Gannon et al. 2015) and decorin (Araki et al. 2009; 
Soria-Valles et al. 2014), but their relevance in humans in 
the context of the anti-oncogenic effects of acute exercise is 
yet to be demonstrated.
There are also several other plausible mechanisms to 
explain the anti-carcinogenic effects of exercise-conditioned 
serum that, to our knowledge, have not been investigated 
in the context of exercise and cancer. For example, IL-6 
release from skeletal muscle during exercise is known to act 
in an endocrine manner to stimulate lipolysis and fatty acid 
oxidation in adipose tissue through the activation of AMPK 
(Kelly et al. 2004). AMPK is known to inhibit mTOR and 
its downstream effectors, such as p70s6k, through a tuber-
ous sclerosis complex 2 (TSC2)‐dependent or ‐independent 
mechanism (Bolster et al. 2002; Kawaguchi et al. 2015). As 
mentioned above, mTOR signalling is dysregulated in many 
cancers, promoting the cell proliferation and metabolism that 
contribute to tumour initiation and progression (Shaw and 
Cantley 2006). Whether muscle-derived IL-6 can similarly 
activate AMPK in distant tissues other than adipocytes, such 
as aberrant or dysplastic cells, and subsequently suppress 
mTOR activity has not been systematically investigated.
Taken together, the signalling pathways that are altered 
by acute-exercise serum, and the serum components respon-
sible for the potential anti-cancer properties, remain largely 
unclear, demonstrating a need for further research in this 
area. It is likely that the mechanisms will be nuanced and 
different depending on a range of factors, including the can-
cer type, the population and the exercise characteristics. It is 
also unlikely to be explained by the effect of a single protein 
or metabolite, but instead probably reflects the synergistic or 
competitive interactions of multiple serological changes that 
occur during and following exercise (although, of course, 
this remains speculative).
A review of the role of the immune system in the impact 
of exercise on cancer cell biology is out of the scope of this 
review (interested readers are directed to a recent review of 
this topic (Koelwyn et al. 2015)), but it is also interesting 
to note that, in addition to the potential direct effects of the 
immune system on the tumour itself, exercise-dependent 
proteomic factors within plasma can have powerful effects 
on circulating immune cells. For example, these factors may 
prime circulating immune cells to develop specific pheno-
types following migration into tissues and differentiation, 
ultimately impacting their function within tissues (Idorn 
and Hojman 2016). As an example, circulating adrenaline 
is involved in the circulatory deployment of natural killer 
T-cells, whilst IL-6 regulates their distribution and activa-
tion, during and following acute exercise (Pedersen et al. 
2016). Thus, exercise-stimulated serological changes are 
involved in both direct and indirect mechanisms that could 
impact upon tumorigenesis and cell growth and develop-
ment in vivo.
Physiological relevance and limitations 
of in vitro cancer models
It has been hypothesised that cumulative, small suppressive 
effects of acute exercise on cancer cell growth, when exer-
cise is performed regularly over several weeks and months, 
would have marked effects on tumour growth in vivo (Deth-
lefsen et al. 2016, 2017b). Yet, it is reasonable to ask: what 
is the relevance of the effects observed in vitro for tumours 
forming and developing in the intact physiological system, 
and are they likely to have any direct consequences for can-
cer prevention and therapy? Indeed, the sceptic could draw 
parallels with circulating anabolic hormones and resistance-
exercise-induced muscle growth: the serum concentration 
of several anabolic hormones, including testosterone, insu-
lin-like growth factor 1, and human growth hormone, are 
increased following acute resistance exercise (Morton et al. 
2016; West et al. 2009, 2010) and they potentiate myocel-
lular growth in vitro (Jacquemin et al. 2004; Sculthorpe et al. 
2012; Serra et al. 2011). However, in humans they have now 
been shown to have limited (if any) impact on the regulation 
of protein dynamics and changes in muscle hypertrophy in 
response to resistance training in vivo (Morton et al. 2016).
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It is first important to consider how representative the 
in  vitro systems are of the physiological scenario. For 
example, an important question is whether a tumour grow-
ing or developing in vivo will be exposed to the active 
component(s) of serum that exerts the suppressive effect on 
growth (as is the case in vitro). In vivo, this will depend on a 
combination of factors, including the level of vascularisation 
and perfusion to the tumour and whether the active proteins 
or metabolites can easily cross the endothelial barrier and 
penetrate into the interstitial fluid bathing the tumour. From 
the latter perspective, tumour vessels are known to be more 
permeable than healthy vessels (Chung et al. 2010) but, nev-
ertheless, the pathway of trans-endothelial transport is likely 
to depend on the size of the anti-carcinogenic protein(s) or 
metabolite(s). Small molecules (< 3 nm, e.g. glucose) are 
able to diffuse easily through inter-endothelial junctions, 
but larger molecules (> 3 nm, e.g. hormones) require trans-
port via receptor-mediated or other transcellular pathways 
(Mehta and Malik 2006). At the same time, tumour vas-
cular networks are heterogeneous, and often immature and 
dysfunctional, leading to highly variable tumour blood flow 
and perfusion across whole tumours, or within different 
regions within a single tumour (Chung et al. 2010; Hughes 
et al. 2019; Schumacher et al. 2020). Poor perfusion of the 
tumour microenvironment can have a direct impact on the 
delivery of nutrients [e.g. creating areas of hypoxia (Hughes 
et al. 2019)] and, by extension, is also likely to mean that 
‘exposure’ of the tumour to anti-oncogenic serological com-
ponents is either low or may be completely absent. Indeed, 
tumours with a dysfunctional vascular tree and poor perfu-
sion are known to be less responsive to systemic pharmaco-
therapies (Gillies et al. 1999). It is important to note, how-
ever, that during exercise there is enhanced blood flow to the 
tumour and decreased tumour hypoxia (McCullough et al. 
2014), suggesting that exercise may increase the delivery of 
circulating factors to the tumour. Irrespective, it is reason-
able to speculate that the acute effects of exercise in vivo are 
likely to be variable and dependent on the specific charac-
teristics of the tumour.
There are several other limitations of in vitro cancer mod-
els. Notably, with the exception of two recent small studies 
(Baldelli et al. 2020; De Santi et al. 2019), the majority of 
work examining the effect of exercise-conditioned media has 
been conducted by using 2D monocultures of tumour cells 
grown on flat plastic surfaces. This does not fully reflect the 
in vivo physiological scenario given that key aspects of the 
tissue architecture and tumour microenvironment, includ-
ing extracellular matrix, cell-to-cell contacts, fibroblasts and 
other tumour-associated stromal cells, are absent in such 
conditions (Kapałczyńska et al. 2018). It is also important to 
consider that only limited work has investigated the effect of 
exercise-conditioned sera on tumour cell migratory potential 
and invasiveness. Although the rate of tumour proliferation 
is an important measure, the rate of tumour growth and its 
metastatic potential do not always correlate. Indeed, in some 
cases, cancerous cells can invade and metastasise before or 
without growing much at the primary site (Dasgupta et al. 
2017; Friberg and Nystrom 2015). The application of 3D 
assays, co-culture systems and/or the use of ‘scaffolds’ mim-
icking the extracellular matrix, will be necessary to over-
come some of these limitations (Kapałczyńska et al. 2018) 
and will provide a more physiologically relevant examina-
tion of the effects of exercise-conditioned medium.
Another important limitation of the currently available 
in vitro studies is that they all employed established tumour 
cell lines. These cell lines might fail to predict in vivo 
tumour responses because of their restricted capacity to 
recapitulate inter-tumour and intra-tumour heterogeneity 
even when derived from the same tissue. In addition, the 
studies conducted to date have only demonstrated that exer-
cise-conditioned sera reduce growth of already transformed 
cancer cells and do not permit to determine whether sero-
logical changes induced by exercise can inhibit the trans-
formation of healthy or aberrant cells into cancerous cells.
Finally, it should also be noted that the suppressive effect 
on viability / growth only becomes detectable when the can-
cer cells are incubated with post-exercise serum in vitro for 
24–96 h (or longer for clonogenic assays) (Baldelli et al. 
2020; Dethlefsen et al. 2016, 2017a; Devin et al. 2019; 
Hwang et al. 2020; Kurgan et al. 2017; Rundqvist et al. 
2013). An important translational consideration here is that 
the serum that the cancer cells are incubated with represents 
a ‘snapshot’ of the serological profile at one brief time point 
during a rapidly changing post-exercise period. During the 
in vitro assay, the cancer cells are continuously exposed to 
the serum and so the suppressive effect is presumably active 
(stimulated) throughout the duration of the assay (24–96 h). 
Of course, in the in vivo physiological system, a tumour will 
never be exposed for a prolonged period of time to post-
exercise serum within a ‘snapshot’ in time, but rather, it will 
be exposed to the serological profile as it transitions through 
a period of disrupted homeostasis during exercise and as 
it recovers back to ‘baseline’ in the hours after exercise. 
On this basis, it is reasonable to question whether in vitro 
findings on the effect of exercise-conditioned serum on can-
cer cell behaviour are ever likely to be truly reflective of 
the in vivo scenario. Two key questions concerning physi-
ological relevance arise from this reasoning; first, how long 
does the anti-carcinogenic effect of serum last into the post-
exercise period? As discussed above, the current data on 
this are somewhat ambiguous, with some studies reporting 
that the effect is short-lived and lost in serum collected 2 h 
post-exercise (Devin et al. 2019), and others detecting effects 
of serum collected up to 24 h post-exercise (Baldelli et al. 
2020; Kurgan et al. 2017). A clear answer to this question, 
and how the time-course of the effect might be impacted by 
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the characteristics of the exercise bout, such as relative exer-
cise intensity, duration and mode, is crucial, as it will pro-
vide a clearer indication of the likely duration of exposure 
of a tumour to the anti-carcinogenic mediators in vivo and 
it will allow clearer inferences on the likely relevance of the 
effects observed in vitro. Second, it will also be important to 
determine whether the alterations in cancer cell proliferation 
require continual stimulation with the active component(s) 
of the post-exercise serum or whether a brief, transient 
exposure results in downstream signalling alterations that 
affect proliferation even if the ‘stimulator’ is removed (i.e. a 
priming effect). From this perspective, it will be interesting 
for future research to perform (epi)genomic/transcriptomic 
profiling of cancer cells exposed to post-exercise serum to 
investigate whether priming effects may be involved.
Conclusions
A number of tentative conclusions can be drawn from the 
current review (summarised in Fig. 3). First, in humans, 
acute exercise appears to be associated with serological 
changes that suppress cancer cell growth but do not induce 
apoptosis in vitro. It remains unclear how long after exer-
cise cessation the anti-growth effect persists; it is almost 
certainly observed immediately post-exercise with a variety 
of aerobic and HIIE protocols, but some studies report that 
the effect is lost soon after exercise and some have observed 
the effect for up to 24 h post-exercise (Table 1). Importantly, 
there appears to be no effect of exercise training on serum-
stimulated cancer cell proliferation when blood samples are 
taken at a time point when the acute effects of the last bout 
Fig. 3  Summary of the effect of acute-exercise- vs chronic-exercise-
conditioned serum on human cancer cell biology. In humans, acute 
exercise serum (collected 0–24  h post exercise) induces serological 
changes that suppress cancer cell growth but that do not appear to 
induce apoptosis in vitro. In comparison, there appears to be no effect 
of exercise-training-conditioned serum (collected > 24 h post chronic 
exercise, when the acute effects of the last bout of exercise have sub-
sided) on cancer cell proliferation
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of exercise have subsided (i.e. > 24 h post exercise). Taken 
together, these findings suggest that the serological effects 
of exercise may be an important mechanism underlying the 
beneficial effects of physical activity and exercise on cancer 
risk and outcome. The presence of an acute but not a training 
effect may have important practical implications for exercise 
prescription for cancer prevention and treatment, suggest-
ing that a high frequency of exercise may be important to 
maximise the effects.
However, in many ways, our understanding in this area 
is in its infancy and there are number of important ques-
tions that required further investigation (summarised in 
Fig. 4). Applying more rigorous study designs to system-
atically comparing the effects of different exercise char-
acteristics, particularly intensity, duration and mode, on 
cancer cell behaviour, will provide important information 
from the perspective of exercise prescription, but may also 
help to elucidate the underpinning molecular mechanisms, 
for example by comparing and contrasting exercise bouts 
that are effective and ineffective. At the same time, it will 
be important to clarify whether the acute effects of exer-
cise are attenuated with repeated bouts, particularly given 
that the effects of training (without weight loss) appear to 
be limited. Perhaps most importantly, a key area for future 
research should be to characterise the effect of exercise-
conditioned serum on in vitro cancer cell models that are 
more representative of the in vivo environment (e.g. patient-
derived organoids, co-culture systems, pre-malignant pol-
yps etc.). It is also reasonable to expect that the population 
from which the sera is derived may modify the subsequent 
responses to exercise. Indeed, it has recently been shown that 
age-associated changes in the serological environment can 
encourage tumour aggressiveness and metastasis (Gomes 
et al. 2020). Thus, characterising the effects of exercise on 
cancer cell behaviour in a range of different populations will 
be key. An overarching aim, encompassing each of these 
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proliferation using in vitro models that are more representative of the in vivo environment 
(e.g., patient-derived organoids, co-culture systems etc).  
cancer cell behaviour in vitro, including apoptosis and invasiveness/migration.  
acute-exercise sera on cancer cell migration/invasiveness.  
exercise on in vitro cancer cell behaviours using appropriate randomised controlled study 
designs. investigated these questions using appropriate study designs. 
characteristics (e.g., sex, age, ethnicity, training status, body composition, health status, etc). 
may be altered with repeated exposure (e.g., over the course of a training programme).  
exercise on serum-stimulated cancer cell growth may be attenuated with training. More evidence 
Include multiple (consistent across studies) post-exercise time points (up to 72-h) in studies 
of acute exercise on serum-stimulated cancer cell behaviour in order to characterise the 
Acute exercise results in changes in a plethora of molecules during exercise and in the post-
exercise period. The time-course of each protein, metabolite or RNA molecule responsible for 
frequency.  
of pre-malignant, dysplastic cancer cells in vitro (such as adenomatous polyps).  
Research to date has focused on malignant cells, which has limited application to cancer 
prevention. Identifying whether acute exercise modulates the progression of pre-malignant, 
dysplastic cells is crucial to improve our understanding of how exercise reduces cancer risk. 
Employ multi-omic techniques (e.g. epigenomics, transcriptomics, metabolomics and 
proteomics) to exercise-conditioned serum as well as cancer cells in vitro following serum 
stimulation.  
regulating cancel cell growth/proliferation. This will help with the development of optimal 
physical activity recommendations and reveal molecular targets that can be manipulated with 
and overall dose, on a range of serum-stimulated cancer cell behaviours in vitro, using 
randomised controlled designs, and ensuring that post-training serum samples are taken at 
Few training studies in humans have been conducted and, although current evidence suggests 
designs are needed. Studies to date have largely focused on cell growth/proliferation and further 
studies on other hallmarks of cancer cell behaviour are needed.  
Fig. 4  A roadmap of key research opportunities on exercise-conditioned serum and cancer cell behaviour
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questions, should be to provide a precise time course of the 
responses, with the addition of multi-omic profiling applied 
in synergy, to help identify the active ingredients of exercise-
conditioned sera and the molecular signalling pathways in 
cancer cells underlying the phenotypic effects. Answering 
these questions will bring together expertise in exercise 
physiology and cancer biology, ultimately improving our 
understanding of the relationship between physical activ-
ity and cancer to allow us to optimise recommendations for 
cancer prevention, treatment and survivorship, and identify 
novel therapeutic targets.
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